Search filters

List of works by Morten Mau-Sorensen

A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma

scientific article published on 24 February 2015

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours

scientific article published on 24 November 2020

A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.

scientific article published on 23 March 2017

A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers

scientific article published on 11 November 2014

A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24

scientific article published on 02 August 2019

A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours

scientific article

A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3.

scientific article published on 27 March 2015

A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer

scientific article published on 22 July 2019

Application of cell-free DNA for genomic tumor profiling: a feasibility study

scientific article published on 15 February 2019

Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab.

scientific article

Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial

scientific article

Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors

scientific article published on 24 August 2018

Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic Study.

scientific article published on 22 February 2017

Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols

scientific article published in October 2017

Copenhagen Prospective Personalized Oncology (CoPPO) - Clinical utility of using molecular profiling to select patients to phase 1 trials

scientific article published on 01 October 2018

Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancer.

scientific article published on 9 May 2015

Detection of copy number alterations in cell-free tumor DNA from plasma

scientific article published on 4 April 2017

Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies

scientific article published on 10 October 2016

Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 - a retrospective case series

scientific article published on 12 September 2015

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer

scientific article published on 05 December 2019

Enhanced detection of circulating tumor DNA by fragment size analysis

scientific article published on 01 November 2018

Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors.

scientific article published on 7 October 2015

First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors

scientific article

High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer

scientific article published on 21 June 2019

Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours.

scientific article published on 5 August 2015

Patient information in phase 1 trials: A systematic review

scientific article published on 27 September 2017

Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment

scientific article published on 01 September 2019

Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma.

scientific article published on 9 February 2015

Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease

scientific article

Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

scientific article published on 9 June 2017

Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients

scientific article published on 12 June 2019

Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients

scientific article published on 12 February 2014

Randomised feasibility study of a more liberal haemoglobin trigger for red blood cell transfusion compared to standard practice in anaemic cancer patients treated with chemotherapy

scientific article

Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom's macroglobulinemia

scientific article published on 4 December 2017

Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.

scientific article

Serum tumor markers in bile duct cancer--a review.

scientific article published on 23 May 2014

Socioeconomic Differences in Referral to Phase I Cancer Clinical Trials: A Danish Matched Cancer Case-Control Study

scientific article published on 12 March 2019

TOP1 gene copy numbers are increased in cancers of the bile duct and pancreas

article

The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2.

scientific article published on 25 November 2014

Three-year follow-up of implementation of evidence-based transfusion practice in a tertiary hospital.

scientific article published on 20 February 2017

Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial

scientific article published on 08 February 2019

Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial

scientific article

Paulina is supported by:

About Paulina

Help